View Single Post
  #1  
Old Tue Jun 8, 2010, 01:05 PM
Birgitta-A Birgitta-A is offline
Member
 
Join Date: Oct 2007
Location: Stockholm, Sweden
Posts: 1,918
Sapacitabine shows 35% improved patients

Hi all,
Now results from the Sapacitabine Phase II study - 61 patients - have been reported. The 7-day high dose schedule got the best result with 35 % improved patients.
http://production.investis.com/cyc/i...10/2010-06-07/
Kind regards
Birgitta-A
Reply With Quote